BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive: Given that NCB progenitors were more sensitive to ABT-199 than CML progenitors, we determined if BCL2 levels were higher in the former, since high BCL2 expression levels predict ABT-199-sensitivity [15].